Provided by Tiger Trade Technology Pte. Ltd.

Usana Health Sciences

15.01
-0.1100-0.73%
Volume:4K
Turnover:57.41K
Market Cap:277.04M
PE:-12.44
High:15.14
Open:15.05
Low:14.91
Close:15.12
52wk High:31.15
52wk Low:12.57
Shares:18.46M
Float Shares:9.93M
Volume Ratio:0.30
T/O Rate:0.04%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.2068
EPS(LYR):0.5793
ROE:-5.06%
ROA:3.61%
PB:0.53
PE(LYR):25.91

Loading ...

Dec 10, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 05, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Oct 22, 2025

Major Issues Report

Form 8-K - Current report
Oct 09, 2025

Major Issues Report

Form 8-K - Current report
Aug 28, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 05, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Jul 30, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jul 22, 2025

Major Issues Report

Form 8-K - Current report
Jul 01, 2025

Major Issues Report

Form 8-K - Current report
Jun 20, 2025

Employee Stock Ownership

Form 11-K - Annual report of employee stock purchase, savings and similar plans
May 27, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 21, 2025

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
May 20, 2025

Major Issues Report

Form 8-K - Current report
May 09, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 06, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Apr 22, 2025

Major Issues Report

Form 8-K - Current report
Mar 12, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 12, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 12, 2025

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 10, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities